News

Alzheimer’s disease represents one of the largest remaining unsolved threats to our health. This disease in common with other neurological disorders has been elusive because it is hard to diagnose. Our current ability to diagnose Alzheimer’s disease...

Institut du Cerveau - ICM is seeking to recruit group leaders to reinforce its research in Neurophysiology, and welcomes applications for recruit highly talented individuals with the ambition to establish an internationally competitive research group...

How can we know if a patient is conscious if he or she is unable to communicate? Disorders of consciousness can be differentiated in two types: the “vegetative” state, with no awareness from the patient and the “minimally conscious” state, with a...

Prof. Cori Bargmann from Rockefeller University was at the Brain and Spine Institute – Institut du Cerveau - ICM on June 6th 2017 to give a conference on « Neuromodulatory regulation through timescales in C. Elegans nematodes ».

Restlessness in sleep is common, however it may be a symptom of two illnesses that seem to be complete opposites: sleepwalking and behavioral disorders in REM sleep. The first affects a younger population and takes place during deep sleep, whereas...

NeoNeuro SAS and the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) group are pleased to announce that they have entered into a collaboration to validate the performance of the Aptamarker platform for Alzheimer's disease...

The first WIRED (Workshop on Intracranial Recordings in humans : Epilepsy, DBS) will be held at the Institut du Cerveau - ICM on October 3 and 4. Conferences, technical discussions, poster session, commercial solutions, wine and cheese… all...

A collaborative study between Philippe Fossati’s team at Paris Brain Institute, a team from KU Leuven and a team from the University of Maastricht, shows for the first time that the brain bases of emotions vary with time.

Teams from AP-HP in collaboration with Paris Brain Institute researchers (Inserm/CNRS/UPMC) and CNRS-derived startup Metafora Biosystems have developed a diagnostic blood test for De Vivo disease, a rare yet treatable neurological illness.

Prof. Eva Maria Kramer Albers from Johannes Gutenberg University, visited the Brain and Spine Institute - Institut du Cerveau - ICM on April 24, 2017 to give a talk on exosomes, biomolecular sacs that may play a part in maintaining neural axon...

24Chronic social defeat stress is a cause in many cases of depression. In humans, chronic social stress is built over time based on our past social interaction, with numerous consequences on both a psychological and neurological level.

A recent study directed by Professor Harald Hampel, researcher at the Institut du Cerveau - ICM, highlights the predictive potential for Alzheimer’s disease of a serological biomarker.